Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 23, 2022

SELL
$26.2 - $54.0 $3,484 - $7,182
-133 Reduced 14.91%
759 $27,000
Q2 2022

Aug 16, 2022

BUY
$26.2 - $54.0 $13,493 - $27,810
515 Added 136.6%
892 $31,000
Q1 2022

May 16, 2022

BUY
$38.58 - $83.27 $2,932 - $6,328
76 Added 25.25%
377 $19,000
Q4 2021

Feb 14, 2022

SELL
$75.47 - $135.88 $5,886 - $10,598
-78 Reduced 20.58%
301 $23,000
Q3 2021

Nov 16, 2021

SELL
$95.64 - $131.48 $43,994 - $60,480
-460 Reduced 54.83%
379 $41,000
Q2 2021

Aug 16, 2021

BUY
$88.13 - $142.06 $20,974 - $33,810
238 Added 39.6%
839 $112,000
Q1 2021

May 17, 2021

BUY
$105.48 - $207.97 $29,639 - $58,439
281 Added 87.81%
601 $74,000
Q4 2020

Feb 16, 2021

BUY
$76.64 - $167.89 $10,729 - $23,504
140 Added 77.78%
320 $45,000
Q3 2020

Nov 17, 2020

BUY
$45.46 - $78.79 $8,182 - $14,182
180 New
180 $14,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.55B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.